Literature DB >> 27380651

Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Alan A Parsa1, Maria I New2.   

Abstract

Congenital adrenal hyperplasia (CAH) refers to a group of inherited genetic disorders involving deficiencies in enzymes that convert cholesterol to cortisol within the adrenal cortex. There are five key enzymes involved in the production of cortisol. Of these key enzymes, deficiency of 21-hydroxylase is the most commonly defective enzyme leading to CAH representing more than 90% of cases. The low adrenal cortisol levels associated with CAH affects the hypothalamic-pituitary-adrenal negative feedback system leading to increased pituitary adrenocorticotropic hormone (ACTH) production, which overstimulates the adrenal cortex in an attempt to increase cortisol production resulting in a hyperplastic adrenal cortex. The deficiency of enzyme 21-hydroxylase results from mutations or deletions in the CYP21A2 gene found on chromosome 6p. The disorder is transmitted as an autosomal recessive pattern and specific mutations may be correlated to enzymatic compromise of varying degrees, leading to the clinical manifestation of 21-hydroxylase deficiency (21-OHD) CAH. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  21 hydroxylase deficiency; CAH; Congenital adrenal hyperplasia

Mesh:

Substances:

Year:  2016        PMID: 27380651     DOI: 10.1016/j.jsbmb.2016.06.015

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  21 in total

1.  Functional analysis of human cytochrome P450 21A2 variants involved in congenital adrenal hyperplasia.

Authors:  Chunxue Wang; Pradeep S Pallan; Wei Zhang; Li Lei; Francis K Yoshimoto; Michael R Waterman; Martin Egli; F Peter Guengerich
Journal:  J Biol Chem       Date:  2017-05-24       Impact factor: 5.157

2.  Issues with the Detection of Large Genomic Rearrangements in Molecular Diagnosis of 21-Hydroxylase Deficiency.

Authors:  Paola Concolino
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

3.  CONGENITAL ADRENAL HYPERPLASIA WITH COMPOUND HETEROZYGOUS I2 SPLICE AND P453S MUTATIONS.

Authors:  B Almacan; N Ozdemir; H Onay; Z Hekimsoy
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Apr-Jun       Impact factor: 1.104

Review 4.  Developmental programming of insulin resistance: are androgens the culprits?

Authors:  Muraly Puttabyatappa; Robert M Sargis; Vasantha Padmanabhan
Journal:  J Endocrinol       Date:  2020-06       Impact factor: 4.286

Review 5.  Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.

Authors:  Paola Concolino; Alessandra Costella
Journal:  Mol Diagn Ther       Date:  2018-06       Impact factor: 4.074

6.  Molecular Analysis of 21-Hydroxylase Deficiency Reveals Two Novel Severe Genotypes in Affected Newborns.

Authors:  Paola Concolino; Rosa Maria Paragliola
Journal:  Mol Diagn Ther       Date:  2021-03-12       Impact factor: 4.074

7.  Health problems of adolescent and adult patients with 21-hydroxylase deficiency.

Authors:  Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2018-10-30

8.  Perioperative care of congenital adrenal hyperplasia - a disparity of physician practices in Canada.

Authors:  Munier A Nour; Hardave Gill; Prosanta Mondal; Mark Inman; Kristine Urmson
Journal:  Int J Pediatr Endocrinol       Date:  2018-09-10

Review 9.  MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.

Authors:  Lina Schiffer; Punith Kempegowda; Wiebke Arlt; Michael W O'Reilly
Journal:  Eur J Endocrinol       Date:  2017-05-31       Impact factor: 6.664

10.  Corticosteroid Biosynthesis Revisited: No Direct Hydroxylation of Pregnenolone by Steroid 21-Hydroxylase.

Authors:  Steffen Loke; Anna Stoll; David Machalz; Francesco Botrè; Gerhard Wolber; Matthias Bureik; Maria Kristina Parr
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-03       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.